Pages that link to "Q50112353"
Jump to navigation
Jump to search
The following pages link to Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. (Q50112353):
Displayed 50 items.
- Vitamin D receptor and epigenetics in HIV infection and drug abuse (Q26782833) (← links)
- Calcium sensing receptor signalling in physiology and cancer (Q26851297) (← links)
- Calcium-Sensing Receptor Gene: Regulation of Expression (Q28079054) (← links)
- Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease (Q28583746) (← links)
- Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas (Q30845693) (← links)
- Regulation of bone remodeling: impact of novel therapies (Q32029051) (← links)
- Vitamin D and the epigenome. (Q33569349) (← links)
- Physiology and pathophysiology of the extracellular calcium-sensing receptor (Q33609407) (← links)
- Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D. (Q33878430) (← links)
- Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia (Q33893460) (← links)
- Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease (Q33917786) (← links)
- Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia (Q33919801) (← links)
- Management of renal hyperparathyroidism (Q33983813) (← links)
- Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium (Q34061518) (← links)
- Differential gene expression by oxyphil and chief cells of human parathyroid glands (Q34274874) (← links)
- Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism (Q34362759) (← links)
- Renal osteodystrophy (Q34436411) (← links)
- Molecular mechanisms of primary hyperparathyroidism (Q34437592) (← links)
- Label-free intraoperative parathyroid localization with near-infrared autofluorescence imaging (Q34628319) (← links)
- Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor (Q34856298) (← links)
- Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs (Q35026640) (← links)
- The calcium-sensing receptor and calcimimetics in blood pressure modulation (Q35376000) (← links)
- Efficacy of early treatment with calcimimetics in combination with reduced doses of vitamin d sterols in dialysis patients (Q35573639) (← links)
- The Pathophysiology of Secondary Hyperparathyroidism and the Consequences of Uncontrolled Mineral Metabolism in Chronic Kidney Disease: The Role of COSMOS. (Q35573642) (← links)
- Update on genetic and clinical aspects of primary hyperparathyroidism (Q35583393) (← links)
- The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. (Q35928870) (← links)
- Calcium sensing by endocrine cells (Q36004163) (← links)
- Primary hyperparathyroidism. Update on pathophysiology, clinical presentation and surgical treatment (Q36013618) (← links)
- The calcium-sensing receptor in normal physiology and pathophysiology: a review (Q36033289) (← links)
- Structural organization and biological relevance of oscillatory parathyroid hormone secretion (Q36034225) (← links)
- Cinacalcet HCl: a novel therapeutic for hyperparathyroidism (Q36082068) (← links)
- Expression of calcium sensing receptor and E-cadherin correlated with survival of lung adenocarcinoma (Q36247888) (← links)
- Regulation of parathyroid function in chronic renal failure. (Q36406660) (← links)
- Paricalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease (Q36428517) (← links)
- Minimizing bone abnormalities in children with renal failure (Q36561062) (← links)
- Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. (Q36571114) (← links)
- Medical therapy of secondary hyperparathyroidism in chronic kidney disease: old and new drugs (Q36632228) (← links)
- Clinical lessons from the calcium-sensing receptor (Q36712977) (← links)
- Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease (Q36853299) (← links)
- Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth (Q36938854) (← links)
- Phosphate Toxicity in CKD: The Killer among Us (Q36965142) (← links)
- Cinacalcet reduces the set point of the PTH-calcium curve (Q36985741) (← links)
- Relative Citation Ratio of Top Twenty Macedonian Biomedical Scientists in PubMed: A New Metric that Uses Citation Rates to Measure Influence at the Article Level (Q37006542) (← links)
- Mineral metabolism and bone abnormalities in children with chronic renal failure (Q37050485) (← links)
- Vitamin D receptor activation and survival in chronic kidney disease. (Q37089710) (← links)
- Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients (Q37095019) (← links)
- New strategies for the treatment of hyperparathyroidism incorporating calcimimetics (Q37111857) (← links)
- Bone and mineral disorders in pre-dialysis CKD. (Q37119865) (← links)
- Parathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism (Q37231801) (← links)
- Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift? (Q37310824) (← links)